Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,295.50
+25.50 (2.01%)
May 14, 2025, 4:59 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 78.96 billion as of May 14, 2025. Its market cap has decreased by -36.44% in one year.
Market Cap
78.96B
Enterprise Value
75.88B
Revenue
21.64B
Ranking
n/a
PE Ratio
10.41
Stock Price
1,295.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 78.96B, an increase of 2,043.33%. That is a compound annual growth rate of 13.28%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,946.97B |
| Coloplast | 142.80B |
| Demant | 54.45B |
| ALK-Abelló | 36.74B |
| H. Lundbeck | 29.45B |
| Zealand Pharma | 29.32B |
| Ambu A/S | 27.76B |
| GN Store Nord | 13.96B |